These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8560314)

  • 1. Quality of life assessment in pediatric oncology: a retrospective review of phase III reports.
    Bradlyn AS; Harris CV; Spieth LE
    Soc Sci Med; 1995 Nov; 41(10):1463-5. PubMed ID: 8560314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality-of-life research in the Pediatric Oncology Group: 1991-1995.
    Bradlyn AS; Pollock BH
    J Natl Cancer Inst Monogr; 1996; (20):49-53. PubMed ID: 8750466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pediatric Oncology Group (POG).
    Bradlyn AS; Pollock BH
    J Natl Cancer Inst Monogr; 1996; (20):89-90. PubMed ID: 8750476
    [No Abstract]   [Full Text] [Related]  

  • 4. Childrens Cancer Group (CCG).
    MacLean WE
    J Natl Cancer Inst Monogr; 1996; (20):87-8. PubMed ID: 8750475
    [No Abstract]   [Full Text] [Related]  

  • 5. Do oncologists have an increasing interest in the quality of life of their patients? A literature review of the last 15 years.
    Batel-Copel LM; Kornblith AB; Batel PC; Holland JC
    Eur J Cancer; 1997 Jan; 33(1):29-32. PubMed ID: 9071895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-reported conflicts of interest of authors, trial sponsorship, and the interpretation of editorials and related phase III trials in oncology.
    Bariani GM; de Celis Ferrari AC; Hoff PM; Krzyzanowska MK; Riechelmann RP
    J Clin Oncol; 2013 Jun; 31(18):2289-95. PubMed ID: 23630201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of life end points in cancer clinical trials: review and recommendations.
    Moinpour CM; Feigl P; Metch B; Hayden KA; Meyskens FL; Crowley J
    J Natl Cancer Inst; 1989 Apr; 81(7):485-95. PubMed ID: 2646455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the informed consent process for randomized clinical trials in pediatric and adult oncology.
    Simon CM; Siminoff LA; Kodish ED; Burant C
    J Clin Oncol; 2004 Jul; 22(13):2708-17. PubMed ID: 15226338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methodology standards associated with quality reporting in clinical studies in pediatric surgery journals.
    Thakur A; Wang EC; Chiu TT; Chen W; Ko CY; Chang JT; Atkinson JB; Fonkalsrud EW; Grosfeld JL
    J Pediatr Surg; 2001 Aug; 36(8):1160-4. PubMed ID: 11479847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Communication about the risks and benefits of phase I pediatric oncology trials.
    Hazen RA; Zyzanski S; Baker JN; Drotar D; Kodish E
    Contemp Clin Trials; 2015 Mar; 41():139-45. PubMed ID: 25638751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality-of-life outcomes in oncology.
    Siddiqui F; Kachnic LA; Movsas B
    Hematol Oncol Clin North Am; 2006 Feb; 20(1):165-85. PubMed ID: 16580562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between progression-free survival and patients' quality of life in cancer clinical trials.
    Hwang TJ; Gyawali B
    Int J Cancer; 2019 Apr; 144(7):1746-1751. PubMed ID: 30374970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Setting the bar in phase II trials: the use of historical data for determining "go/no go" decision for definitive phase III testing.
    Vickers AJ; Ballen V; Scher HI
    Clin Cancer Res; 2007 Feb; 13(3):972-6. PubMed ID: 17277252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiation Therapy Oncology Group quality of life assessment: design, analysis, and data management issues.
    Scott CB; Stetz J; Bruner DW; Wasserman TH
    Qual Life Res; 1994 Jun; 3(3):199-206. PubMed ID: 7920494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compliance issues in quality of life assessment: experiences of two Cancer Research Campaign sponsored groups.
    Fallowfield L
    Stat Med; 1998 Mar 15-Apr 15; 17(5-7):541-6. PubMed ID: 9549803
    [No Abstract]   [Full Text] [Related]  

  • 16. Quality of life assessment in Southwest Oncology Group trials.
    Moinpour CM; Hayden KA; Thompson IM; Feigl P; Metch B
    Oncology (Williston Park); 1990 May; 4(5):79-84, 89; discussion 104. PubMed ID: 2143413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enrollment in early-phase clinical trials in pediatric oncology: The experience at Institut Curie.
    Surun A; Dujaric MÉ; Aerts I; Orbach D; Jiménez I; Pacquement H; Schleiermacher G; Bourdeaut F; Michon J; Dupont JK; Doz F
    Pediatr Blood Cancer; 2018 May; 65(5):e26916. PubMed ID: 29334194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. United Kingdom Cancer Research Campaign approach to quality-of-life research in cancer clinical trials.
    Hopwood P
    J Natl Cancer Inst Monogr; 1996; (20):103-5. PubMed ID: 8750479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing quality of life in research and clinical practice.
    Jacobsen PB; Davis K; Cella D
    Oncology (Williston Park); 2002 Sep; 16(9 Suppl 10):133-9. PubMed ID: 12380963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complementary and alternative medicine among advanced cancer patients enrolled on phase I trials: a study of prognosis, quality of life, and preferences for decision making.
    Hlubocky FJ; Ratain MJ; Wen M; Daugherty CK
    J Clin Oncol; 2007 Feb; 25(5):548-54. PubMed ID: 17290064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.